中西医结合心血管病电子杂志
中西醫結閤心血管病電子雜誌
중서의결합심혈관병전자잡지
Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine (Electronic)
2014年
4期
9-10
,共2页
阿布都克尤木·阿不力米提
阿佈都剋尤木·阿不力米提
아포도극우목·아불력미제
肺心病%舒利迭%思力华
肺心病%舒利迭%思力華
폐심병%서리질%사력화
Cor%Seretide%Spiriva
目的:探讨舒利迭联合思力华治疗慢性阻塞性肺心病患者的临床效果。方法选择2012-2013年入我院进行治疗的56例中重度稳定器慢性阻塞性肺心病患者,随机分为试验组和对照组,每组患者28例,试验组采用舒利迭联合思力华治疗,对照组仅采用舒利迭治疗,治疗时间为3个月。在治疗前后观察记录两组患者临床症状、肺功能指数、血气分析结果并进行比较。结果在足疗程治疗后,试验组和对照组的患者临床症状均得到改善,试验组临床症状缓解率明显优于对照组患者;治疗后试验组和对照组患者的动脉血气分析结果均得到改善,两组患者在整个治疗期间无明显不良反应。结论采用舒利迭合并思力华治疗慢性阻塞性肺心病取得了较好的临床效果,且不良反应少,起效快,值得在临床中应用。
目的:探討舒利迭聯閤思力華治療慢性阻塞性肺心病患者的臨床效果。方法選擇2012-2013年入我院進行治療的56例中重度穩定器慢性阻塞性肺心病患者,隨機分為試驗組和對照組,每組患者28例,試驗組採用舒利迭聯閤思力華治療,對照組僅採用舒利迭治療,治療時間為3箇月。在治療前後觀察記錄兩組患者臨床癥狀、肺功能指數、血氣分析結果併進行比較。結果在足療程治療後,試驗組和對照組的患者臨床癥狀均得到改善,試驗組臨床癥狀緩解率明顯優于對照組患者;治療後試驗組和對照組患者的動脈血氣分析結果均得到改善,兩組患者在整箇治療期間無明顯不良反應。結論採用舒利迭閤併思力華治療慢性阻塞性肺心病取得瞭較好的臨床效果,且不良反應少,起效快,值得在臨床中應用。
목적:탐토서리질연합사력화치료만성조새성폐심병환자적림상효과。방법선택2012-2013년입아원진행치료적56례중중도은정기만성조새성폐심병환자,수궤분위시험조화대조조,매조환자28례,시험조채용서리질연합사력화치료,대조조부채용서리질치료,치료시간위3개월。재치료전후관찰기록량조환자림상증상、폐공능지수、혈기분석결과병진행비교。결과재족료정치료후,시험조화대조조적환자림상증상균득도개선,시험조림상증상완해솔명현우우대조조환자;치료후시험조화대조조환자적동맥혈기분석결과균득도개선,량조환자재정개치료기간무명현불량반응。결론채용서리질합병사력화치료만성조새성폐심병취득료교호적림상효과,차불량반응소,기효쾌,치득재림상중응용。
Objective To investigate the joint Seretide Spiriva clinical effects of chronic obstructive pulmonary heart disease patients.Methods 2012 -2013 into the hospital for treatment of moderate to severe stabilizer patients with chronic obstructive pulmonary heart disease,56 cases were randomly divided into experimental group and control group,28 patients in each group,the experimental group using Seretide Spiriva joint treatment,the control group,only the use of Seretide treatment for 3 months.Before and after treatment groups were observed and recorded clinical symptoms,lung function indices,blood gas analysis and the results were compared.After the full course of treatment results in the test group and the control group of patients with clinical symptoms were improved,the test group of clinical symptoms was significantly better than the control group of patients;experimental group and a control group of patients with arterial blood gas a-nalysis results were improved after treatment,two groups of patients throughout the treatment period no significant adverse reactions.Conclusion Seretide Spiriva combined treatment of chronic obstructive pulmonary heart disease achieved better clinical results and fewer side effects,rapid onset,worthy of clinical applica-tion.